Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue? Authors' Reply

被引：0
|
作者：
Wang, Ting [1 ,2 ]
Zou, Deli [1 ]
Qi, Xingshun [1 ,2 ]
机构：
[1] Shenyang Pharmaceut Univ, Gen Hosp Northern Theater Command, Teaching Hosp, Dept Gastroenterol, Shenyang, Peoples R China
[2] Shenyang Pharmaceut Univ, Dept Life Sci & Biopharmaceut, Shenyang, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
关键词：
ACUTE KIDNEY INJURY; INCREASE; SURVIVAL;
D O I：
10.1111/apt.18371
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：194 / 197
页数：4
相关论文
共 3 条
  • [1] Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue?
    Alferink, Louise J. M.
    de Knegt, Robert J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 192 - 193
  • [2] Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' reply
    Wijarnpreecha, Karn
    Li, Fang
    Taner, C. Burcin
    Yang, Liu
    Tao, Cui
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (05) : 728 - 729
  • [3] Correspondence on Editorial regarding "Baveno- VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients"
    Wong, Yu Jun
    Sharma, Sanchit
    Tosetti, Giuia
    Qi, Xiaolong
    Primignani, Massimo
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 188 - 190
1